GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Other Operating Expense

ME Therapeutics Holding (XCNQ:METX) Other Operating Expense : C$-0.02 Mil (TTM As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Other Operating Expense?

ME Therapeutics Holding's Other Operating Expense for the three months ended in Feb. 2024 was C$-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.02 Mil.

ME Therapeutics Holding's quarterly Other Operating Expense declined from Aug. 2023 (C$0.00 Mil) to Nov. 2023 (C$-0.02 Mil) but then increased from Nov. 2023 (C$-0.02 Mil) to Feb. 2024 (C$-0.00 Mil).

ME Therapeutics Holding's annual Other Operating Expense increased from . 20 (C$0.00 Mil) to Aug. 2022 (C$-0.02 Mil) and increased from Aug. 2022 (C$-0.02 Mil) to Aug. 2023 (C$0.00 Mil).

ME Therapeutics Holding Other Operating Expense Historical Data

The historical data trend for ME Therapeutics Holding's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Other Operating Expense Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Other Operating Expense
-0.02 -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Other Operating Expense Get a 7-Day Free Trial - - - -0.02 -

ME Therapeutics Holding Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ME Therapeutics Holding Other Operating Expense Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

ME Therapeutics Holding (XCNQ:METX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Other Operating Expense
Comparable Companies
Traded in Other Exchanges
Q9T:Germany
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
Website
https://www.metherapeutics.com
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines